InvestorsHub Logo
Followers 32
Posts 1169
Boards Moderated 0
Alias Born 12/12/2005

Re: exwannabe post# 110035

Thursday, 01/31/2013 11:10:23 AM

Thursday, January 31, 2013 11:10:23 AM

Post# of 345969
ex,

Again and IMO, the bad HR and P value results for the TH-302 trial was probably an unfortunate fluke and that type of issue probably isn't going to happen with the bavi trial. Also, there is no cross-over in the bavi trial.

I brought up the point about the FDA granting a SPA for their phase 3 trial because, IMO, the FDA could see that there was an issue with the control arm and took that into account as part of making their decision.


All IMO,

mojo
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News